AR004052A1 - Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico - Google Patents

Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico

Info

Publication number
AR004052A1
AR004052A1 ARP960104829A ARP960104829A AR004052A1 AR 004052 A1 AR004052 A1 AR 004052A1 AR P960104829 A ARP960104829 A AR P960104829A AR P960104829 A ARP960104829 A AR P960104829A AR 004052 A1 AR004052 A1 AR 004052A1
Authority
AR
Argentina
Prior art keywords
cosmetic
beta
pharmaceutical composition
adrenergic agonist
composition including
Prior art date
Application number
ARP960104829A
Other languages
English (en)
Original Assignee
Oréal L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oréal L filed Critical Oréal L
Publication of AR004052A1 publication Critical patent/AR004052A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a la utilización de al menos un agonista beta-adrenérgico en una composición cosmética como antagonista de substancia Po para la preparación de una composición farmacéutica, más particularmente dermatológica,d estinada a tratar las alteraciones asociadas con un exceso desíntesis y/o de liberación de substancia P. La invención se refiere igualmente a una composición cosmética o farmacéutica, para uso tópico, que comprende almenos un agonistabeta-adrenérgi co y un procedimiento de tratamiento cosmético con miras a disminuir el dolor relacionado con un exceso de síntesis y/o deliberación de substancia P o disminuir el efecto irritante de una composición cosmética.
ARP960104829A 1995-10-23 1996-10-21 Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico AR004052A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9512447A FR2740040B1 (fr) 1995-10-23 1995-10-23 Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p

Publications (1)

Publication Number Publication Date
AR004052A1 true AR004052A1 (es) 1998-09-30

Family

ID=9483809

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104829A AR004052A1 (es) 1995-10-23 1996-10-21 Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico

Country Status (14)

Country Link
US (2) US5958432A (es)
EP (1) EP0769293B1 (es)
JP (1) JP3636473B2 (es)
AR (1) AR004052A1 (es)
BR (1) BR9611302A (es)
CA (1) CA2222311C (es)
DE (1) DE69603681T2 (es)
DK (1) DK0769293T3 (es)
FR (1) FR2740040B1 (es)
HU (1) HUP9900511A3 (es)
NO (1) NO312273B1 (es)
PL (1) PL186366B1 (es)
RU (1) RU2169552C2 (es)
WO (1) WO1997015281A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948972A (en) * 1994-12-22 1999-09-07 Kla-Tencor Corporation Dual stage instrument for scanning a specimen
AU8298801A (en) * 2000-07-26 2002-02-05 John K Vyden Methods for treating atopic disorders
ITPD20010187A1 (it) * 2001-07-23 2003-01-23 Cutech Srl Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
EP1295599A1 (en) * 2001-09-21 2003-03-26 Boehringer Ingelheim International GmbH Method for the treatment of prevention of atopic dermatitis
US20030219573A1 (en) * 2002-03-27 2003-11-27 Torgny Falk Absorbent product
US8343519B2 (en) * 2003-02-19 2013-01-01 L'oreal S.A. Chemical enhancer and method
EP1613266A4 (en) * 2003-04-15 2009-05-06 Theraquest Biosciences Llc METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
CA2589001A1 (en) * 2004-11-19 2006-05-26 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for neuropathic pain
ES2348920T3 (es) 2005-04-13 2010-12-17 Astion Development A/S Agonistas de adrenoceptores beta-2 para el tratamiento de enfermedades del tejido conectivo de la piel.
CA2715110A1 (fr) * 2008-01-18 2009-09-17 Centre National De La Recherche Scientifique (Cnrs) Composes utilisables pour le traitement de douleurs neuropathiques
GB0805535D0 (en) * 2008-03-27 2008-04-30 Univ Leicester Scar prevention
US8420114B2 (en) * 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
JP5425229B2 (ja) * 2009-02-24 2014-02-26 ノバルティス アーゲー Nk受容体アンタゴニストの使用
GB2513297A (en) 2013-03-08 2014-10-29 Univ Leicester Methods
JP6659819B2 (ja) 2015-07-09 2020-03-04 ガルデルマ・ソシエテ・アノニム 化学療法に関連する脱毛の軽減方法
JP7152051B2 (ja) * 2018-05-29 2022-10-12 株式会社ナノエッグ アトピー性皮膚炎を治療または予防するための組成物
WO2020051568A1 (en) * 2018-09-08 2020-03-12 Wen Tan NEW USE OF R-ENANTIOMER OF ADRENERGIC β2 RECEPTOR AGONISTS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE AND ITS EXTRA INTESTINAL MANIFESTATIONS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
US4038417A (en) * 1975-06-19 1977-07-26 Nelson Research & Development Company Method for treatment of psoriasis
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5366731A (en) * 1990-08-24 1994-11-22 Wisconsin Alumni Research Foundation Cosmetic compositions containing secosterol compounds
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
JPH07258067A (ja) * 1994-03-18 1995-10-09 Kao Corp 浴用剤組成物
FR2719474B1 (fr) * 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.

Also Published As

Publication number Publication date
US6267972B1 (en) 2001-07-31
JP2000503628A (ja) 2000-03-28
NO976143L (no) 1998-06-03
MX9710475A (es) 1998-08-30
BR9611302A (pt) 1999-03-30
PL324924A1 (en) 1998-06-22
CA2222311A1 (fr) 1997-05-01
DE69603681D1 (de) 1999-09-16
NO976143D0 (no) 1997-12-30
JP3636473B2 (ja) 2005-04-06
WO1997015281A1 (fr) 1997-05-01
EP0769293A3 (fr) 1997-05-02
EP0769293B1 (fr) 1999-08-11
FR2740040A1 (fr) 1997-04-25
HUP9900511A3 (en) 2000-09-28
FR2740040B1 (fr) 1997-12-05
EP0769293A2 (fr) 1997-04-23
RU2169552C2 (ru) 2001-06-27
DK0769293T3 (da) 1999-12-06
DE69603681T2 (de) 1999-11-25
HUP9900511A2 (hu) 1999-07-28
PL186366B1 (pl) 2003-12-31
NO312273B1 (no) 2002-04-22
CA2222311C (fr) 2006-11-28
US5958432A (en) 1999-09-28

Similar Documents

Publication Publication Date Title
AR004052A1 (es) Una composición cosmética o farmacéutica que comprende un agonista beta-adrenergico
AR003989A1 (es) Composicion cosmetica o farmaceutica y procedimiento de tratamiento cosmetico, excluido tdo tratamiento terapeutico que utiliza la composicion cosmetica.
ES2159382T3 (es) Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones.
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
MXPA02007822A (es) Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa.
ES2063073T3 (es) Derivados de arilmetilenilo conocidos y nuevos seleccionados de tiazolidinonas, imidazolidinonas y oxazolidinonas utiles como agentes antialergicos y agentes antiinflamatorios.
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
ES2081110T3 (es) Composicion cosmetica o farmaceutica, particularmente dermatologica, destinada a favorecer la pigmentacion de la piel o de los cabellos, que contiene un extracto de cyperus y su procedimiento de fabricacion.
ES2157684T3 (es) Composicion de blanqueo de la piel y/o de los cabellos.
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
ES2176795T3 (es) Composiciones a base de esfingomielanasa y su utilizacion.
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
AR017222A1 (es) Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos
RU95103892A (ru) Композиция топического нанесения для стимулирования роста волос и/или замедления их выпадения, способ косметического лечения волос, применение производного альфа -пирона для получения композиции
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
ATE259210T1 (de) Trichologische lotion für die topische anwendung
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
PT817625E (pt) Composicoes para o tratamento de pele fotodanificada, compreendendo um antagonista de rar-alfa e um retinoide multi-selectivo
ES2174337T3 (es) Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular.
BR9814937A (pt) Utilização de uma quantidade suficiente de pelo menos um extrato de pelo um vegetal do gênero chrysanthemum, composição cosmética ou farmacêutica e processo de tratamento cosmético.
ATE237331T1 (de) Deuterierte wirkstoffe in transdermaler applikation
AR004326A1 (es) Utilizacion de al menos un antagonista de tnf-alfa, composicion cosmetica, farmaceutica o dermatologica que contiene dicho antagonista y procedimiento detratamiento cosmetico empleando dicho antagonista.
ES2136954T3 (es) Utilizacion de al menos un agua termal de vichy como antagonista de sustancia p.
ES2071112T3 (es) Utilizacion de un extracto de coleus para la pigmentacion de la piel.

Legal Events

Date Code Title Description
FC Refusal